ClinVar Miner

Submissions for variant NM_000186.4(CFH):c.3647C>A (p.Thr1216Lys)

dbSNP: rs1653050051
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Sydney Genome Diagnostics, Children's Hospital Westmead RCV001328247 SCV001449225 uncertain significance Atypical hemolytic-uremic syndrome 2019-02-21 no assertion criteria provided clinical testing This individual is heterozygous for the c.3647C>A variant in the CFH gene, which results in the amino acid substitution of threonine to lysine at residue 1216, p.(Thr1216Lys). The variant has not been reported in any population databases (i.e. gnomAD, ExAC, ESP or dbSNP). To our knowledge, this variant has not been previously reported in the literature or any disease specific databases. In silico analysis of pathogenicity (through Alamut Visual v2.8.1) using PolyPhen2, SIFT and MutationTaster suggest that this variant does not affect protein function and is likely to be benign. However, this analysis alone cannot be used to exclude pathogenicity. This variant is considered to be a variant of uncertain clinical significance (VOUS) according to the ACMG guidelines. (Evidence used: PM2, BP4)

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.